CLINICAL PHARMACOLOGY AND THERAPEUTIC APPLICATIONS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CAPTOPRILFERGUSON RK; VLASSES PH.1981; AM. HEART. J.; ISSN 0002-8703; USA; DA. 1981; VOL. 101; NO 5; PP. 650-656; BIBL. 57 REF.Article

EFFECTS OF CAPTOPRIL, DIURETIC, AND THEIR COMBINATION IN LOW-RENIN ESSENTIAL HYPERTENSIONFERGUSON RK; VLASSES PH; SWANSON BN et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 25-26; PP. 2519-2522; BIBL. 17 REF.Article

SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE IN NORMAL-RENIN AND LOW-RENIN ESSENTIAL HYPERTENSION.FERGUSON RK; TUREK DM; ROVNER DR et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 21; NO 1; PP. 62-69; BIBL. 1 P.Article

CLINICAL USE OF CAPTOPRIL: ILLUSTRATIVE CASESFERGUSON RK; ROTMENSCH HH; VLASSES PH et al.1982; JAMA, J AM. MED. ASSOC.; ISSN 0098-7484; USA; DA. 1982; VOL. 247; NO 15; PP. 2117-2119; BIBL. 8 REF.Article

AMINODARONE-BENEFITS AND RISKS IN PERSPECTIVEROTMENSCH HH; BELHASSEN B; FERGUSON RK et al.1982; AMERICAN HEART JOURNAL; ISSN 0002-8703; USA; DA. 1982; VOL. 104; NO 5; PART. 1; PP. 1117-1119; BIBL. 28 REF.Article

INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME: THERAPEUTIC IMPLICATIONSROTMENSCH HH; VLASSES PH; FERGUSON RK et al.1982; ISRAEL JOURNAL OF MEDICAL SCIENCES; ISSN 0021-2180; ISR; DA. 1982; VOL. 18; NO 10; PP. 981-985; BIBL. 39 REF.Article

AN INVESTIGATION OF PHARMACOLOGIC AND BEHAVIORAL TOLERANCE TO MORPHINE IN RATS = ETUDE DE LA TOLERANCE PHARMACOLOGIQUE ET DU COMPORTEMENT ENVERS LA MORPHINE CHEZ LES RATSKAYAN S; FERGUSON RK; MITCHELL CL et al.1973; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1973; VOL. 185; NO 2; PP. 300-306; BIBL. 19REF.Serial Issue

INFLUENCE OF CIMETIDINE ON THE PHARMACOKINETICS OF MORPHINE IN RATSMOJAVERIAN P; SWANSON BN; DUDASH ML et al.1982; RES. COMMUN. SUBST. ABUSE; ISSN 504122; USA; DA. 1982; VOL. 3; NO 1; PP. 1-10; BIBL. 2 P.Article

LOW-DOSE CAPTOPRILVLASSES PH; ROTMENSCH HH; SWANSON BN et al.1982; ARCH. INTERN. MED. (1960); ISSN 0003-9926; USA; DA. 1982; VOL. 142; NO 6; PP. 1098-1101; BIBL. 28 REF.Article

CAPTOPRIL WITHDRAWAL AFTER CHRONIC THERAPYVLASSES PH; KOFFER H; FERGUSON RK et al.1981; CLIN. EXP. HYPERTENS.; ISSN 0148-3927; USA; DA. 1981; VOL. 3; NO 5; PP. 929-937; BIBL. 14 REF.Article

NORFLOXACIN DISPOSITION AFTER SEQUENTIALLY INCREASING ORAL DOSESSWANSON BN; BOPPANA VK; VLASSES PH et al.1983; ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; ISSN 0066-4804; USA; DA. 1983; VOL. 23; NO 2; PP. 284-288; BIBL. 7 REF.Article

PERIPHERAL NEUROPATHY AFTER CONCOMITANT ADMINISTRATION OF DIMETHYL SULFOXIDE AND SULINDACSWANSON BN; FERGUSON RK; RASKIN NH et al.1983; ARTHRITIS AND RHEUMATISM; ISSN 0004-3591; USA; DA. 1983; VOL. 26; NO 6; PP. 791-793; BIBL. 11 REF.Article

CONGESTIVE HEART FAILURE IN NORMOTENSIVE MAN: HAEMODYNAMICS, RENIN, AND ANGIOTENSIN II BLOCKADETURINI GA; BRUNNER HR; FERGUSON RK et al.1978; BRIT. HEART J.; GBR; DA. 1978; VOL. 40; NO 10; PP. 1134-1142; BIBL. 1 P.Article

"SCALDED MOUTH" CAUSED BY ANGIOTENSIN-CONVERTING-ENZYME INHIBITORSVLASSES PH; ROTMENSCH HH; FERGUSON RK et al.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 63300; PP. 1672-1673; BIBL. 5 REF.Article

MECHANISM OF BLOOD PRESSURE REDUCTION BY TEPROTIDE (SQ 20881) IN RATS.JAEGER P; FERGUSON RK; BRUNNER HR et al.1978; KIDNEY INTERNATION.; GERM.; DA. 1978; VOL. 13; NO 4; PP. 289-295; ABS. FR.; BIBL. 32 REF.Article

RELATIONSHIPS OF RENIN AND ALDOSTERONE TO ANTIHYPERTENSIVE EFFECTS OF SPIRONOLACTONE AND PROPRANOLOL.JAEGER P; FERGUSON RK; BRUNNER HR et al.1978; J. CLIN. PHARMACOL.; USA; DA. 1978; VOL. 18; NO 7; PP. 311-318; BIBL. 19 REF.Article

ANGIOTENSIN CONVERTING ENZYME ACTIVITY IN HUMAN SERUM RELATIONSHIP TO ENZYME INHIBITOR IN VIVO AND IN VITROSWANSON BN; HICHENS M; PARVIZ MOJAVERIAN et al.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 33; NO 3; PP. 525-536; BIBL. 3 P.Article

COMPARISON OF ORAL INDACRINONE WITH FUROSEMIDEIRVIN JD; VLASSES PH; HUBER PB et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 3; PP. 376-383; BIBL. 14 REF.Article

RELATIONSHIPS AMONG TIMOLOL DOSES, PLASMA CONCENTRATIONS AND BETA -ADRENOCEPTOR BLOCKING ACTIVITYFERGUSON RK; VLASSES PH; KOPLIN JR et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 5; PP. 719-725; BIBL. 16 REF.Article

CAPTOPRIL IN SEVERE TREATMENT-RESISTANT HYPERTENSIONFERGUSON RK; VLASSES PH; KOPLIN SR et al.1980; AMER. HEART J.; USA; DA. 1980; VOL. 99; NO 5; PP. 579-585; BIBL. 15 REF.Article

NEED FOR BETA-BLOCKADE IN HYPERTENSION REDUCED WITH LONG-TERM MINOXIDIL.BRUNNER HR; JAEGER P; FERGUSON RK et al.1978; BRIT. MED. F.; GBR; DA. 1978; NO 6134; PP. 385-388; BIBL. 13 REF.Article

MINOXIDIL A LONG TERME: RENINE, ALDOSTERONE, NORADRENALINE ET BESOIN DE BETA -BLOQUANTSJAEGER P; BRUNNER HR; TURINI GA et al.1978; SCHWEIZ. MED. WSCHR.; CHE; DA. 1978; VOL. 108; NO 44; PP. 1707-1709; ABS. ENG; BIBL. 11 REF.Article

IMMEDIATE-RELEASE AND SUSTAINED-RELEASE PROCAINAMIDE: BIOAVAILABILITY AT STEADY STATE IN CARDIAC PATIENTSVLASSES PH; ROCCI ML JR; PORRINI KA et al.1983; ANNALS OF INTERNAL MEDICINE; ISSN 0003-4819; USA; DA. 1983; VOL. 98; NO 5; PP. 613-614; BIBL. 6 REF.Article

EVIDENCE FOR ROUTE DEPENDENT BIOTRANSFORMATION OF CYCLOBENZAPRINE HYDROCHLORIDETILL AE; CONSTANZER ML; DEMETRIADES J et al.1982; BIOPHARM. DRUG DISPOS.; ISSN 0142-2782; GBR; DA. 1982; VOL. 3; NO 1; PP. 19-28; BIBL. 8 REF.Article

SULINDAC DISPOSITION WHEN GIVEN ONCE AND TWICE DAILYSWANSON BN; BOPPANA VK; VLASSES PH et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 3; PP. 397-403; BIBL. 19 REF.Article